Report Detail

Request for Sample of this report

Other COVID-19 Impact on Global Clinical Next-Generation Sequencing Market Size, Status and Forecast 2020-2026

  • RnM3985124
    • |
  • 03 June, 2020
    • |
  • Global
    • |
  • 90 Pages
    • |
  • QYResearch
    • |
  • Other

Next-generation sequencing (NGS) has been rapidly integrated into molecular pathology, dramatically increasing the breadth genomic of information available to oncologists and their patientseration sequencing.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Clinical Next-Generation Sequencing market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Clinical Next-Generation Sequencing industry.
Based on our recent survey, we have several different scenarios about the Clinical Next-Generation Sequencing YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Clinical Next-Generation Sequencing will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Clinical Next-Generation Sequencing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Clinical Next-Generation Sequencing market in terms of revenue.
Players, stakeholders, and other participants in the global Clinical Next-Generation Sequencing market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Clinical Next-Generation Sequencing market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Clinical Next-Generation Sequencing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Clinical Next-Generation Sequencing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Clinical Next-Generation Sequencing market.
The following players are covered in this report:
Thermo Fisher Scientific
PerkinElmer
Illumina
Beckman Coulter
GATC Biotech
Qiagen
...
Clinical Next-Generation Sequencing Breakdown Data by Type
Targeted Sequencing
Exome Sequencing
Others
Clinical Next-Generation Sequencing Breakdown Data by Application
Hospitals and Clinics
Biopharma Companies
Academic and Research Organizations
Others


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Clinical Next-Generation Sequencing Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Clinical Next-Generation Sequencing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Targeted Sequencing
    • 1.4.3 Exome Sequencing
    • 1.4.4 Others
  • 1.5 Market by Application
    • 1.5.1 Global Clinical Next-Generation Sequencing Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals and Clinics
    • 1.5.3 Biopharma Companies
    • 1.5.4 Academic and Research Organizations
    • 1.5.5 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Clinical Next-Generation Sequencing Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Clinical Next-Generation Sequencing Industry
      • 1.6.1.1 Clinical Next-Generation Sequencing Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Clinical Next-Generation Sequencing Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Clinical Next-Generation Sequencing Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Clinical Next-Generation Sequencing Market Perspective (2015-2026)
  • 2.2 Clinical Next-Generation Sequencing Growth Trends by Regions
    • 2.2.1 Clinical Next-Generation Sequencing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Clinical Next-Generation Sequencing Historic Market Share by Regions (2015-2020)
    • 2.2.3 Clinical Next-Generation Sequencing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Clinical Next-Generation Sequencing Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Clinical Next-Generation Sequencing Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Clinical Next-Generation Sequencing Players by Market Size
    • 3.1.1 Global Top Clinical Next-Generation Sequencing Players by Revenue (2015-2020)
    • 3.1.2 Global Clinical Next-Generation Sequencing Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Clinical Next-Generation Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Clinical Next-Generation Sequencing Market Concentration Ratio
    • 3.2.1 Global Clinical Next-Generation Sequencing Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Clinical Next-Generation Sequencing Revenue in 2019
  • 3.3 Clinical Next-Generation Sequencing Key Players Head office and Area Served
  • 3.4 Key Players Clinical Next-Generation Sequencing Product Solution and Service
  • 3.5 Date of Enter into Clinical Next-Generation Sequencing Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Clinical Next-Generation Sequencing Historic Market Size by Type (2015-2020)
  • 4.2 Global Clinical Next-Generation Sequencing Forecasted Market Size by Type (2021-2026)

5 Clinical Next-Generation Sequencing Breakdown Data by Application (2015-2026)

  • 5.1 Global Clinical Next-Generation Sequencing Market Size by Application (2015-2020)
  • 5.2 Global Clinical Next-Generation Sequencing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Clinical Next-Generation Sequencing Market Size (2015-2020)
  • 6.2 Clinical Next-Generation Sequencing Key Players in North America (2019-2020)
  • 6.3 North America Clinical Next-Generation Sequencing Market Size by Type (2015-2020)
  • 6.4 North America Clinical Next-Generation Sequencing Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Clinical Next-Generation Sequencing Market Size (2015-2020)
  • 7.2 Clinical Next-Generation Sequencing Key Players in Europe (2019-2020)
  • 7.3 Europe Clinical Next-Generation Sequencing Market Size by Type (2015-2020)
  • 7.4 Europe Clinical Next-Generation Sequencing Market Size by Application (2015-2020)

8 China

  • 8.1 China Clinical Next-Generation Sequencing Market Size (2015-2020)
  • 8.2 Clinical Next-Generation Sequencing Key Players in China (2019-2020)
  • 8.3 China Clinical Next-Generation Sequencing Market Size by Type (2015-2020)
  • 8.4 China Clinical Next-Generation Sequencing Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Clinical Next-Generation Sequencing Market Size (2015-2020)
  • 9.2 Clinical Next-Generation Sequencing Key Players in Japan (2019-2020)
  • 9.3 Japan Clinical Next-Generation Sequencing Market Size by Type (2015-2020)
  • 9.4 Japan Clinical Next-Generation Sequencing Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Clinical Next-Generation Sequencing Market Size (2015-2020)
  • 10.2 Clinical Next-Generation Sequencing Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Clinical Next-Generation Sequencing Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Clinical Next-Generation Sequencing Market Size by Application (2015-2020)

11 India

  • 11.1 India Clinical Next-Generation Sequencing Market Size (2015-2020)
  • 11.2 Clinical Next-Generation Sequencing Key Players in India (2019-2020)
  • 11.3 India Clinical Next-Generation Sequencing Market Size by Type (2015-2020)
  • 11.4 India Clinical Next-Generation Sequencing Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Clinical Next-Generation Sequencing Market Size (2015-2020)
  • 12.2 Clinical Next-Generation Sequencing Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Clinical Next-Generation Sequencing Market Size by Type (2015-2020)
  • 12.4 Central & South America Clinical Next-Generation Sequencing Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Thermo Fisher Scientific
    • 13.1.1 Thermo Fisher Scientific Company Details
    • 13.1.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
    • 13.1.3 Thermo Fisher Scientific Clinical Next-Generation Sequencing Introduction
    • 13.1.4 Thermo Fisher Scientific Revenue in Clinical Next-Generation Sequencing Business (2015-2020))
    • 13.1.5 Thermo Fisher Scientific Recent Development
  • 13.2 PerkinElmer
    • 13.2.1 PerkinElmer Company Details
    • 13.2.2 PerkinElmer Business Overview and Its Total Revenue
    • 13.2.3 PerkinElmer Clinical Next-Generation Sequencing Introduction
    • 13.2.4 PerkinElmer Revenue in Clinical Next-Generation Sequencing Business (2015-2020)
    • 13.2.5 PerkinElmer Recent Development
  • 13.3 Illumina
    • 13.3.1 Illumina Company Details
    • 13.3.2 Illumina Business Overview and Its Total Revenue
    • 13.3.3 Illumina Clinical Next-Generation Sequencing Introduction
    • 13.3.4 Illumina Revenue in Clinical Next-Generation Sequencing Business (2015-2020)
    • 13.3.5 Illumina Recent Development
  • 13.4 Beckman Coulter
    • 13.4.1 Beckman Coulter Company Details
    • 13.4.2 Beckman Coulter Business Overview and Its Total Revenue
    • 13.4.3 Beckman Coulter Clinical Next-Generation Sequencing Introduction
    • 13.4.4 Beckman Coulter Revenue in Clinical Next-Generation Sequencing Business (2015-2020)
    • 13.4.5 Beckman Coulter Recent Development
  • 13.5 GATC Biotech
    • 13.5.1 GATC Biotech Company Details
    • 13.5.2 GATC Biotech Business Overview and Its Total Revenue
    • 13.5.3 GATC Biotech Clinical Next-Generation Sequencing Introduction
    • 13.5.4 GATC Biotech Revenue in Clinical Next-Generation Sequencing Business (2015-2020)
    • 13.5.5 GATC Biotech Recent Development
  • 13.6 Qiagen
    • 13.6.1 Qiagen Company Details
    • 13.6.2 Qiagen Business Overview and Its Total Revenue
    • 13.6.3 Qiagen Clinical Next-Generation Sequencing Introduction
    • 13.6.4 Qiagen Revenue in Clinical Next-Generation Sequencing Business (2015-2020)
    • 13.6.5 Qiagen Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Clinical Next-Generation Sequencing. Industry analysis & Market Report on COVID-19 Impact on Global Clinical Next-Generation Sequencing is a syndicated market report, published as COVID-19 Impact on Global Clinical Next-Generation Sequencing Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Clinical Next-Generation Sequencing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,900.00
    		$5,850.00
    		$7,800.00
    		3,120.00
    		4,680.00
    		6,240.00
    		3,642.60
    		5,463.90
    		7,285.20
    		613,587.00
    		920,380.50
    		1,227,174.00
    		325,221.00
    		487,831.50
    		650,442.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo